SUPN
Supernus Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +1.6% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +2 | 42.40M | $1.97B | +5 | −5 |
| Q1 2026 | 104 | -3 | 41.20M | $2.13B | +5 | −9 |
| Q4 2025 | 107 | 0 | 43.16M | $2.15B | +1 | n/a |
| Q3 2025 | 18 | -1 | 27.64M | $1.32B | n/a | −2 |
| Q2 2025 | 17 | 0 | 22.78M | $717.88M | n/a | n/a |
| Q1 2025 | 14 | 0 | 6.75M | $221.22M | n/a | n/a |
| Q4 2024 | 14 | 0 | 6.49M | $234.56M | +1 | −1 |
| Q3 2024 | 13 | 0 | 4.54M | $141.67M | +1 | −1 |
| Q2 2024 | 13 | n/a | 4.27M | $114.18M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 9.37M | n/a | $295.28M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (pasivo) | 6.21M | n/a | $195.59M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasivo) | 2.21M | +3.0% | $69.61M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 1.66M | +4.4% | $52.18M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 1.40M | +5.5% | $44.12M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 598.62K | +27.9% | $18.87M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Point72 Asset Management ✦ | 507.79K | +59.2% | $16.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 247.98K | -3.3% | $7.82M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 175.13K | +8.4% | $5.52M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 140.56K | +64.9% | $4.43M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 11 | Fidelity (FMR) ✦ | 80.85K | n/a | $2.55M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 57.30K | -41.1% | $1.81M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 47.30K | +11.2% | $1.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Norges Bank ✦ (pasivo) | 31.41K | -55.7% | $989,886 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Wellington Management ✦ | 20.99K | -5.5% | $661,700 | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 16 | Gotham Asset Management ✦ | 17.62K | -42.6% | $555,477 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Millennium Management ✦ | 13.07K | -90.9% | $412,061 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 323 tenedores, 57.94M acciones, $2.88B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.